Creative Planning Corcept Therapeutics Inc Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Creative Planning holds 12,467 shares of CORT stock, worth $621,479. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,467

Previous 11,626 7.23%

Holding current value

$621,479

Previous $377,000 52.79%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$29.51 - $46.26 $24,817 - $38,904	841 Added 7.23%	12,467 $576,000
Q2 2024 Aug 15, 2024	BUY	$22.21 - $34.48 $39,844 - $61,857	1,794 Added 18.25%	11,626 $377,000
Q1 2024 May 10, 2024	BUY	$21.1 - $27.46 $58,911 - $76,668	2,792 Added 39.66%	9,832 $247,000
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $174,732 - $231,475	7,040 New	7,040 $228,000
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $178,368 - $227,326	9,290 New	9,290 $201,000
Q1 2020 May 05, 2020	SELL	$10.11 - $14.04 $173,184 - $240,505	-17,130 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$12.06 - $16.96 $206,587 - $290,524	17,130 New	17,130 $207,000
Q1 2019 Apr 24, 2019	SELL	$10.03 - $15.71 $134,000 - $209,885	-13,360 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$11.29 - $17.19 $280,962 - $427,790	-24,886 Reduced 65.07%	13,360 $178,000
Q3 2018 Oct 25, 2018	BUY	$12.27 - $15.65 $93,080 - $118,720	7,586 Added 24.74%	38,246 $536,000
Q2 2018 Jul 20, 2018	SELL	$15.3 - $19.69 $12,576 - $16,185	-822 Reduced 2.61%	30,660 $482,000
Q1 2018 Apr 18, 2018	BUY	$14.59 - $25.5 $63,043 - $110,185	4,321 Added 15.91%	31,482 $518,000
Q4 2017 Jan 17, 2018	BUY	$15.77 - $20.72 $190,012 - $249,655	12,049 Added 79.73%	27,161 $491,000
Q3 2017 Oct 17, 2017	BUY	$12.3 - $19.3 $185,877 - $291,661	15,112	15,112 $292,000

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.34B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Corcept Therapeutics Inc Transaction History